受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A3061 Batch: A306101
Azintuxizumab (Anti-SLAMF7 / CS1/ CD319/ CRACC) is a monoclonal IgG4 bispecific antibody targeting B-cell maturation antigen (BCMA). It has the potential for the research of relapsed/refractory multiple myeloma (RRMM). MW :140.12 KD.
CAS No. | 1826819-57-1 |
---|---|
Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
Isotype | Human IgG1 |
Source | CHO |
Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Shipping | Shipped under low temperature conditions |
Purity | 99% |
Protein concentration | 9.517mg/ml |
Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。